Research at the Institute of Biomedicine is divided into three functional units: 1) Infection and Immunity, 2) Integrative Physiology and Pharmacology and 3) Cancer research. Research at our Institute includes both biomedical basic research and translational research, and the unit division expresses our research priorities.
We encourage creative interdisciplinary combination of research topics via collaboration of the individual research groups and the three units. In addition, we collaborate locally with clinical researchers, with other institutes of our university and with the Åbo Akademi University. We are also widely networked with numerous national and international universities and public and private research institutes.
Research services
Recent publications
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers (2022)
Molecular Cancer Therapeutics
(Refereed journal article or data article (A1))
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics (2022)
British Journal of Clinical Pharmacology
(Refereed journal article or data article (A1))
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children (2022)
Pediatric Diabetes
(Refereed journal article or data article (A1))
Obesity risk is associated with brain glucose uptake and insulin resistance (2022)
European Journal of Endocrinology
(Refereed journal article or data article (A1))
Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling (2022)
Journal of Clinical Immunology
(Refereed journal article or data article (A1))
Recent doctoral dissertations
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers (2022)
Molecular Cancer Therapeutics
(Refereed journal article or data article (A1))
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics (2022)
British Journal of Clinical Pharmacology
(Refereed journal article or data article (A1))
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children (2022)
Pediatric Diabetes
(Refereed journal article or data article (A1))
Obesity risk is associated with brain glucose uptake and insulin resistance (2022)
European Journal of Endocrinology
(Refereed journal article or data article (A1))
Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling (2022)
Journal of Clinical Immunology
(Refereed journal article or data article (A1))